LaSalle Venture Advisers

Robert Williamson

Mr. Williamson is a seasoned biotech executive with over 20 years of experience building and leading innovative biotechnology companies. Currently, he holds various leadership positions in the industry, including President and COO of Triumvira Immunologics, a cell therapy company, Compensation Committee Chair and Director of Perspective Therapeutics, a radiopharmaceutical company listed on the NYSE, and senior adviser to SyntheX, a protein interaction and degrader company. Mr. Williamson has successfully led multiple companies through significant growth, partnerships, financing rounds, IPOs, and successful acquisitions. Notably, he served as an early Director of Pharmasset, Inc., where he helped guide the company's growth and eventual acquisition by Gilead for $11 billion. Prior to his career in biotech, Mr. Williamson was a partner with The Boston Consulting Group and a research assistant for the Federal Reserve Board of Governors in Washington, D.C. He holds a BA in economics from Pomona College and an MBA from Stanford University. Mr. Williamson also serves on the Coulter Oversight Board for University of Miami, FL.